QSAM Biosciences ROCE
Что обозначает ROCE в QSAM Biosciences?
ROCE QSAM Biosciences, Inc. является 427.73%
Какое определение для ROCE?
Рентабельность использованного капитала (ROCE) - это финансовый коэффициент, который измеряет прибыльность компании и эффективность использования ее капитала.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE компаний в Health Care сектор на OTC по сравнению с QSAM Biosciences
Что делает QSAM Biosciences?
QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.
Компании с roce похож на QSAM Biosciences
- PAVmed Inc имеет ROCE из 411.68%
- Q-Gold Resources имеет ROCE из 414.05%
- LiteLink Technologies имеет ROCE из 414.08%
- Empire Industries имеет ROCE из 418.52%
- 102570 имеет ROCE из 421.84%
- Capitan Mining имеет ROCE из 423.79%
- QSAM Biosciences имеет ROCE из 427.73%
- Mustang Bio Inc имеет ROCE из 433.01%
- Sonoro Gold имеет ROCE из 434.69%
- Nevtah Capital Management имеет ROCE из 448.86%
- Richland Resources International имеет ROCE из 448.86%
- Permian Basin Royalty Trust имеет ROCE из 457.43%
- Navigator Acquisition имеет ROCE из 463.12%